12.70

4.35% 0.53

Korro Bio Inc (KRRO)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$12.17

Aprire:

$12.09

Volume 24 ore:

788.71K

Relative Volume:

4.40

Capitalizzazione di mercato:

$183.17M

Reddito:

$6.39M

Utile/perdita netta:

$-117.26M

Rapporto P/E:

-1.0176

EPS:

-12.4807

Flusso di cassa netto:

$-79.08M

1 W Prestazione:

-2.23%

1M Prestazione:

+3.00%

6M Prestazione:

+56.40%

1 anno Prestazione:

+2.92%

Intervallo 1D:

$12.09

$13.14

Intervallo di 1 settimana:

$11.97

$15.09

Portata 52W:

$5.2044

$55.89

Korro Bio Inc Stock (KRRO) Company Profile

Nome

Korro Bio Inc

Settore

Healthcare (1096)

Industria

Biotechnology (615)

Telefono

617-468-1999

Indirizzo

60 FIRST STREET, CAMBRIDGE

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

KRRO's Discussions on Twitter

Compare KRRO vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KRRO Korro Bio Inc	12.70	183.17M	6.39M	-117.26M	-79.08M	-12.48
VRTX Vertex Pharmaceuticals Inc	491.34	124.70B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	632.90	66.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	887.18	55.17B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	291.37	38.90B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	182.08	38.71B	742.00K	-1.37B	-1.07B	-7.0731

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2026-02-17	Aggiornamento	William Blair	Mkt Perform → Outperform
2026-01-29	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2026-01-29	Aggiornamento	H.C. Wainwright	Neutral → Buy
2026-01-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2026-01-28	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2026-01-28	Aggiornamento	Oppenheimer	Perform → Outperform
2025-11-13	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-11-13	Downgrade	Chardan Capital Markets	Buy → Neutral
2025-11-13	Downgrade	H.C. Wainwright	Buy → Neutral
2025-11-13	Downgrade	Piper Sandler	Overweight → Neutral
2025-11-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2025-11-13	Downgrade	Raymond James	Strong Buy → Mkt Perform
2025-11-13	Downgrade	William Blair	Outperform → Mkt Perform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-16	Iniziato	Chardan Capital Markets	Buy
2025-01-10	Iniziato	Oppenheimer	Outperform
2024-10-21	Iniziato	Raymond James	Strong Buy
2024-08-14	Iniziato	William Blair	Outperform
2024-03-28	Reiterato	H.C. Wainwright	Buy
2024-02-27	Iniziato	BMO Capital Markets	Outperform
2023-12-04	Iniziato	H.C. Wainwright	Buy
2023-11-29	Iniziato	RBC Capital Mkts	Outperform
2023-11-10	Iniziato	Piper Sandler	Overweight
2023-02-15	Downgrade	Chardan Capital Markets	Buy → Neutral
2023-02-13	Downgrade	Cowen	Outperform → Market Perform
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-01-27	Aggiornamento	JP Morgan	Neutral → Overweight
2020-12-22	Iniziato	B. Riley Securities	Buy
2020-07-14	Iniziato	Oppenheimer	Outperform
2020-05-18	Downgrade	JP Morgan	Overweight → Neutral
2019-10-28	Iniziato	Cowen	Outperform
2019-10-28	Iniziato	Goldman	Buy
2019-10-28	Iniziato	JP Morgan	Overweight

Mostra tutto

Korro Bio Inc Borsa (KRRO) Ultime notizie

Jun 26, 2026

Korro Bio Insider Sold Shares Worth $2,458,582, According to a Recent SEC Filing - marketscreener.com

Jun 25, 2026

Jun 24, 2026

Korro Bio director Jean Francois Formela sells $2.45m in shares - Investing.com

Jun 24, 2026

Form 144 Korro Bio For: 24 June By Investing.com - Investing.com Canada

Jun 24, 2026

Atlas Venture (KRRO) sells 101,579 shares on 06/23/2026, multiple Form 144 entries - Stock Titan

Jun 24, 2026